Menu
Back to Archived Journals » Core Evidence » Volume 4 » default
Core Evidence ceased publishing in January 2023. All articles that have been published in Core Evidence will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
ISSN: 1555-175X
- View all (143)
- Volume 15, 2020 (4)
- Volume 14, 2019 (6)
- Volume 13, 2018 (3)
- Volume 12, 2017 (2)
- Volume 11, 2016 (5)
- Volume 10, 2015 (9)
- Volume 9, 2014 (13)
- Volume 8, 2013 (7)
- Volume 7, 2012 (12)
- Volume 6, 2011 (7)
- Volume 5, 2010 (9)
- Volume 4, 2009 (20)
- Volume 3, 2008 (5)
- Volume 2, 2007 (22)
- Volume 1-Issues 3 & 4, 2006 (8)
- Volume 1-Issues 1 & 2, 2005 (11)
Archive: Volume 4, 2009
Methylnaltrexone: the evidence for its use in the management of opioid-induced constipation
Peter Deibert, Carola Xander, Hubert E Blum, et al
Core Evidence 2009, 4:247-258
Published Date: 11 December 2009
Lenalidomide in multiple myeloma: an evidence-based review of its role in therapy
Paul Richardson, Constantine Mitsiades, Jacob Laubach, et al
Core Evidence 2009, 4:215-245
Published Date: 17 November 2009
Nilotinib for the treatment of chronic myeloid leukemia: An evidence-based review
Elias Jabbour, Jorge Cortes, Hagop Kantarjian
Core Evidence 2009, 4:207-213
Published Date: 5 October 2009
Efficacy of palifermin (keratinocyte growth factor-1) in the amelioration of oral mucositis
Stephen T Sonis
Core Evidence 2009, 4:199-205
Published Date: 24 August 2009
Trabectedin: the evidence for its place in therapy in the treatment of soft tissue sarcoma
Katherine A Thornton
Core Evidence 2009, 4:191-198
Published Date: 21 August 2009
Tocilizumab: The evidence for its place in the treatment of juvenile idiopathic arthritis
Troels Herlin
Core Evidence 2009, 4:181-189
Published Date: 7 August 2009
Agomelatine: The evidence for its place in the treatment of depression
Daniela Eser, Thomas C Baghai, Hans-Jürgen Möller
Core Evidence 2009, 4:171-179
Published Date: 5 August 2009
Golimumab: A novel human anti-TNF-α monoclonal antibody for the treatment of rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis
Jonathan Kay, Mahboob U Rahman
Core Evidence 2009, 4:159-170
Published Date: 23 July 2009
Etravirine (TMC-125): The evidence for its place in the treatment of HIV-1 infection
Hans-Jürgen Stellbrink
Core Evidence 2009, 4:149-158
Published Date: 22 July 2009
Raltegravir: The evidence of its therapeutic value in HIV-1 infection
Kavya Ramkumar, Nouri Neamati
Core Evidence 2009, 4:131-147
Published Date: 2 July 2009
Lasofoxifene: Evidence of its therapeutic value in osteoporosis
Luigi Gennari, Daniela Merlotti, Vincenzo De Paola, Ranuccio Nuti
Core Evidence 2009, 4:113-129
Published Date: 1 July 2009
Temozolomide: The evidence for its therapeutic efficacy in malignant astrocytomas
Ayman I Omar, Warren P Mason
Core Evidence 2009, 4:93-111
Published Date: 26 June 2009
Conivaptan: Evidence supporting its therapeutic use in hyponatremia
Melissa Li-Ng, Joseph G Verbalis
Core Evidence 2009, 4:83-92
Published Date: 25 June 2009
Desvenlafaxine in major depressive disorder: an evidence-based review of its place in therapy
Daniel Z Lieberman, Suena H Massey
Core Evidence 2009, 4:67-82
Published Date: 25 June 2009
Eptifibatide: The evidence for its role in the management of acute coronary syndromes
Ibrahim Shah, Shakeel O Khan, Surender Malhotra, Tim Fischell
Core Evidence 2009, 4:49-65
Published Date: 18 June 2009
Axitinib: The evidence of its potential in the treatment of advanced thyroid cancer
Hari A Deshpande, Scott Gettinger, Julie Ann Sosa
Core Evidence 2009, 4:43-48
Published Date: 10 June 2009
Indacaterol: a new once daily long-acting beta2 adrenoceptor agonist
Kai M Beeh, Jutta Beier
Core Evidence 2009, 4:37-41
Published Date: 18 June 2009
Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout
Angelo L Gaffo, Kenneth G Saag
Core Evidence 2009, 4:25-36
Published Date: 23 June 2009
Intravenous zoledronic acid for the treatment of osteoporosis: The evidence of its therapeutic effect
E Michael Lewiecki
Core Evidence 2009, 4:13-23
Published Date: 18 June 2009
Exforge® (amlodipine/valsartan combination) in hypertension: the evidence of its therapeutic impact
Jean-Marie Krzesinski, Eric P Cohen
Core Evidence 2009, 4:1-11
Published Date: 17 June 2009